Skip to content

Cyto-Stat Trichrome CD45-FITC/CD19-RD1/CD3-PC5 Monoclonal Antibody Reagent with CD45-FITC/MSIGG1-RD1

by Coulter Corp.

510(k) K982167

Active European Union and United States

CE IVDD 510(k)

Valid until

Not listed

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE 510(k) Substantially Equivalent · Traditional NumberK982167 Date9 Nov 1998ClearedStatusActive
European UnionCE/IVDD EUDAMED Number— Date—StatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · 510(k)

Full name
Cyto-Stat Trichrome CD45-Fitc/CD19-RD1/CD3-PC5 Monoclonal Antibody Reagent with Cyto-Stat Trichrome CD45-Fitc/MSIGG1-RD1
510(k) Number
FDA Product Code
GKZ
Device Class
Class II
Regulation
21 CFR Part 864.5220
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a monoclonal antibody reagent designed for flow cytometric analysis, specifically for the simultaneous identification of CD45, CD19, and CD3 cell surface markers. It employs fluorescent conjugates—FITC, RD1, and PC5—to enable multi-color immunofluorescent staining of white blood cell subsets, aiding in hematological diagnostics and differential cell counting.

The reagent is supplied as a ready-to-use solution for direct immunofluorescent staining in flow cytometry workflows, intended for single-use in clinical hematology laboratories. Authorized under FDA 510(k) clearance (K982167) and In Vitro Diagnostic Device Directive (IVDD), it adheres to Class II regulatory standards (FDA 864.5220) and is classified under the Differential Cell Counter category. No sterility or MRI safety specifications are noted.

Other devices from Coulter Corp.

See all devices from Coulter Corp. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical applications is this monoclonal antibody reagent primarily used for in flow cytometry?

    This reagent is designed for flow cytometric analysis to simultaneously identify CD45, CD19, and CD3 cell surface markers on white blood cells. It aids in hematological diagnostics by enabling multi-color immunofluorescent staining, which helps differentiate and count specific white blood cell subsets, such as lymphocytes (B-cells via CD19, T-cells via CD3) and leukocytes (via CD45). This is particularly useful for diagnosing and monitoring hematological conditions.

  • Is this reagent intended for single-use or can it be reused in multiple tests?

    The reagent is explicitly supplied as a ready-to-use solution for single-use in clinical hematology laboratories. Reuse is not recommended or authorized, as it could compromise accuracy, sterility, or performance in flow cytometry workflows.

  • What regulatory pathways does this device follow, and how does it classify under FDA and IVD regulations?

    The reagent is authorized under FDA 510(k) clearance (K982167) and the In Vitro Diagnostic Device Directive (IVDD), classifying it as a Class II device under FDA category 864.5220 (Differential Cell Counter). It was determined substantially equivalent to a predicate device, with the Hematology (HE) advisory committee reviewing its submission.

  • Does this reagent require special storage conditions, and is it sterile?

    The provided data does not specify sterility requirements or special storage conditions (e.g., temperature, light exposure) for this reagent. However, as a ready-to-use solution for clinical diagnostics, standard laboratory storage practices (e.g., refrigeration if applicable) should be followed to maintain integrity until use. Always refer to the manufacturer’s instructions for precise handling.

  • Are there multiple sizes or models of this reagent available, or is it supplied in a single formulation?

    The data does not mention variations in sizes or models for this specific reagent. It is described as a single formulation—a ready-to-use monoclonal antibody reagent for multi-color flow cytometry—intended for direct immunofluorescent staining of CD45, CD19, and CD3 markers. No additional variants (e.g., different concentrations or volumes) are referenced.